EP.17B.05 Impact of Race and Ethnicity on Financial Toxicity and Outcomes in Lung Cancer
Atulya Aman Khosla(Baptist Hospital of Miami), Aakash Desai(University of Connecticut), Venkataraghavan Ramamoorthy(Baptist Health South Florida), Anshul Saxena(Florida International University), Ishmael Jaiyesimi(Beaumont Hospital, Royal Oak), Indira B Deshmukh(The University of Texas Health Science Center), Rohit Singh(University of Vermont Medical Center), Avi Harisingani(MacNeal Hospital), Nitya Batra(Jacksonville College), Muni Rubens(Florida International University)
Cited by 0
Related Papers
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k
Non–Small Cell Lung Cancer, Version 4.2024
|Journal of the National Comprehensive Cancer Network|2024|805
Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium
|Annals of Oncology|2021|328
Mitigating long-term and delayed adverse events associated with cancer treatment: implications for survivorship
|Nature Reviews Clinical Oncology|2023|296
Mitigating acute chemotherapy-associated adverse events in patients with cancer
|Nature Reviews Clinical Oncology|2022|161